THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Joseph Sassine

Concepts (64)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antibodies, Bispecific
1
2025
9
0.950
Why?
Immunotherapy, Adoptive
1
2025
15
0.950
Why?
Herpesviridae Infections
1
2025
17
0.950
Why?
Hematopoietic Stem Cell Transplantation
2
2021
69
0.890
Why?
Pseudomonas Infections
1
2022
24
0.790
Why?
Cytomegalovirus
1
2021
22
0.760
Why?
Pneumonia
1
2022
89
0.740
Why?
Multiple Myeloma
1
2021
29
0.720
Why?
Anti-Bacterial Agents
5
2025
498
0.510
Why?
Antiviral Agents
2
2025
111
0.400
Why?
Humans
10
2025
27175
0.250
Why?
Herpesviridae
1
2025
3
0.240
Why?
Macrolides
1
2025
19
0.240
Why?
Drug Hypersensitivity
1
2025
23
0.240
Why?
Transplant Recipients
2
2021
12
0.240
Why?
Hematologic Neoplasms
1
2025
18
0.230
Why?
Cytomegalovirus Infections
1
2025
36
0.230
Why?
Coccidioidomycosis
1
2024
13
0.230
Why?
T-Lymphocytes
1
2025
280
0.210
Why?
Sexual and Gender Minorities
1
2023
38
0.210
Why?
Peritoneal Dialysis
1
2021
4
0.190
Why?
Peritonitis
1
2021
15
0.190
Why?
Acetates
1
2021
44
0.190
Why?
Quinazolines
1
2021
31
0.190
Why?
Pseudomonas aeruginosa
1
2022
62
0.190
Why?
Immune Reconstitution
1
2021
1
0.190
Why?
Cryptococcosis
1
2021
31
0.180
Why?
Angiogenesis Inhibitors
1
2021
104
0.170
Why?
Risk Factors
1
2025
2043
0.160
Why?
Retrospective Studies
2
2024
2464
0.150
Why?
Pneumonia, Bacterial
1
2018
18
0.150
Why?
Community-Acquired Infections
1
2018
29
0.150
Why?
Drug Resistance, Multiple, Bacterial
1
2018
23
0.150
Why?
Decision Support Techniques
1
2018
49
0.150
Why?
Aged
3
2024
5232
0.140
Why?
Male
5
2025
13034
0.130
Why?
Bacteria
1
2018
265
0.130
Why?
Incidence
2
2025
553
0.090
Why?
Middle Aged
3
2025
6918
0.070
Why?
Erythromycin
1
2025
13
0.060
Why?
Anaphylaxis
1
2025
6
0.060
Why?
Clarithromycin
1
2025
7
0.060
Why?
Azithromycin
1
2025
11
0.060
Why?
Cross Reactions
1
2025
72
0.060
Why?
Coccidioides
1
2024
14
0.060
Why?
Immunocompromised Host
1
2024
27
0.060
Why?
Homosexuality, Male
1
2023
16
0.050
Why?
Databases, Factual
1
2025
253
0.050
Why?
Antifungal Agents
1
2023
59
0.050
Why?
Comorbidity
1
2024
249
0.050
Why?
Adult
2
2025
7510
0.050
Why?
Female
3
2025
14658
0.050
Why?
Gentamicins
1
2021
15
0.050
Why?
Oklahoma
1
2024
977
0.040
Why?
Child, Preschool
1
2024
1101
0.040
Why?
Antimicrobial Stewardship
1
2018
5
0.040
Why?
Drug Utilization
1
2018
28
0.040
Why?
Treatment Failure
1
2018
68
0.040
Why?
Prospective Studies
1
2021
1224
0.040
Why?
Child
1
2024
2163
0.040
Why?
Young Adult
1
2024
2636
0.030
Why?
Adolescent
1
2024
2996
0.030
Why?
Risk Assessment
1
2018
597
0.030
Why?
Aged, 80 and over
1
2018
1943
0.030
Why?
Sassine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (7)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES